FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer
The FDA has granted priority review to Enhertu for the potential treatment of HER2-low and HER2-ultralow breast cancer.The Food and ...
Tag: breast cancer treatment
Side Effects, Quality of Life Important to Consider in Breast Cancer Subset
Patients receiving Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-positive metastatic breast cancer showed “remarkable” outcomes, although it may have different side effects ...
Presurgical Keytruda-Chemo Combo With Postsurgical Keytruda May Improve Survival in Early TNBC
Patients with early-stage triple-negative breast cancer demonstrated improved survival outcomes after treatment with perioperative (time around surgery) Keytruda (pembrolizumab) with ...
Breast Cancer Treatment May Protect Against Dementia
Some breast cancer survivors may be protected from dementias after receiving select hormone therapies, research found.Hormone-modulating therapy (HMT), which is ...